4//SEC Filing
Szot Matthew K 4
Accession 0001213900-25-127110
CIK 0001937993other
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 4:05 PM ET
Size
5.2 KB
Accession
0001213900-25-127110
Insider Transaction Report
Form 4
Szot Matthew K
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-12-29$6.97/sh−9,933$69,233→ 0 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 18, 2025, in multiple transactions at prices ranging from $6.83 through $7.37, inclusive, having a weighted average price as shown in column 4 of $6.97. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Cadrenal Therapeutics, Inc.
CIK 0001937993
Entity typeother
Related Parties
1- filerCIK 0001401385
Filing Metadata
- Form type
- 4
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 4:05 PM ET
- Size
- 5.2 KB